STAT3 signaling pathway inhibitors (Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Univ of Chinese Academy of Sciences/Nanjing University of Chinese Medicine)

N/A

Report date: 2025/03/20 09:50:19
NME

Base Information

Drug NameSTAT3 signaling pathway inhibitors (Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Univ of Chinese Academy of Sciences/Nanjing University of Chinese Medicine)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Chinese Academy of SciencesNanjing University Of Chinese MedicineShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A